Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,112.20 -206.04 -1.35%
S&P 500 1,628.93 -22.88 -1.39%
Nasdaq 3,443.20 -38.98 -1.12%
Ticker Volume Price Price Delta
STOXX 50 2,683.98 -16.95 -0.63%
FTSE 100 6,348.82 -25.39 -0.40%
DAX 8,197.08 -32.43 -0.39%
Ticker Volume Price Price Delta
Nikkei 13,014.60 -230.64 -1.74%
Hang Seng 20,443.60 -543.29 -2.59%
S&P/ASX 200 4,758.40 -102.98 -2.12%
  • Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment

EYW:GR

75.270 EUR 0.160 0.21%

As of 02:08:12 ET on 06/20/2013.

Company Profile for BioMerieux (EYW)

bioMerieux designs, develops, manufactures, and markets systems in the field of in vitro diagnostics for medical and industrial applications. The Company is specialized in the diagnosis of infectious diseases and pathologies. bioMerieux is also active in the analysis of food, pharmaceuticals, and environmental samples to determine their microbiological quality.

Contact Information

BioMerieux

Marcy L'Etoile, 69280
France
Phone: 33-4-78-87-20-00
Fax: 33-4-78-87-20-90

Key Executives for BioMerieux (EYW)

Jean-Luc BelingardChairman/CEOHenri ThomassonChief Financial Officer
Mark MillerChief Medical OfficerThierry BernardVP:Global Commercial Ops
Jean-Marc DuranoVP:Industrial MicrobiologyAlain PluquetVP:Innovation & Systems
Francois LacosteVP:ImmunoassayAlexandre MerieuxVP:Microbiology

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil